| Oral Multiple-dose Study in Patients With Major Depressive Disorder (NCT01924520) | Astellas Pharma Inc | 2010-11-01 |
| To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function (NCT01240967) | AstraZeneca | 2010-11-01 |
| A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic Impairment (NCT01257178) | Eli Lilly and Company | 2010-11-01 |
| An Absolute Bioavailability Study in Healthy Participants Comparing Oral to Intravenous Administration of GDC-0973 (Cobimetinib) (NCT01249118) | Genentech, Inc. | 2010-11-01 |
| A Novel Combination Oral Agent to Treat Acne Vulgaris (NCT01301586) | Nexgen Dermatologics, Inc. | 2010-11-01 |
| A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005) (NCT01226901) | Merck Sharp & Dohme LLC | 2010-11-01 |
| Phase 1 Follow-on Study of AAV2-hRPE65v2 Vector in Subjects With Leber Congenital Amaurosis (LCA) 2 (NCT01208389) | Spark Therapeutics, Inc. | 2010-11-01 |
| A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline (NCT01250873) | Eli Lilly and Company | 2010-11-01 |
| Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD) (NCT01318330) | HomeoTherapy Co., Ltd | 2010-11-01 |
| A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin (NCT01214122) | AstraZeneca | 2010-11-01 |
| A Study Of PF-05175157 In Healthy Volunteers (NCT01274663) | Pfizer | 2010-11-01 |
| The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam (NCT01221727) | Amgen | 2010-11-01 |
| Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra (NCT01259219) | Harriet Shezi Children's Clinic | 2010-11-01 |
| A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment (NCT01253304) | Eli Lilly and Company | 2010-11-01 |
| An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness (NCT01369589) | Parion Sciences | 2010-11-01 |
| A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses (NCT01244620) | Pfizer | 2010-11-01 |
| A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers (NCT01248052) | Eli Lilly and Company | 2010-11-01 |
| Change in Executive Function and IADL Using a Virtual Supermarket Environment Among People With MCI (NCT01103453) | Carmel Medical Center | 2010-11-01 |
| The Use of Functional Confections in Promoting Oral Health (NCT01514552) | Ohio State University | 2010-11-01 |
| A Study to Determine the Relative Bioavailability of a Tablet Formulation of GDC-0941 and the Effect of Ketoconazole on the Pharmacokinetics of the GDC-0941 Tablet (NCT01240226) | Genentech, Inc. | 2010-11-01 |
| A Study Evaluating the Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 Days (NCT01234142) | Pfizer | 2010-11-01 |
| Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal Impairment (NCT01239459) | Sanofi | 2010-11-01 |
| Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies (NCT01221857) | Gamida Cell ltd | 2010-11-01 |
| T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs (NCT01210664) | University of California, San Francisco | 2010-11-01 |
| Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers (NCT01275612) | Mario Negri Institute for Pharmacological Research | 2010-11-01 |
| Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer (NCT01238770) | Priv.-Doz. Dr. med. Joachim Rom | 2010-11-01 |
| Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions (NCT02322632) | Dr. Reddy's Laboratories Limited | 2010-11-01 |
| Effects of Iron on Exercise Capacity During Hypoxia (NCT01265108) | University of Oxford | 2010-11-01 |
| Oral Bioavailability of Two Solid Formulations of GLPG0259. (NCT01322451) | Lakefront Biotherapeutics NV | 2010-11-01 |
| Safety, Tolerability, and Pharmacokinetics of MK-8266 in Elderly Participants With High Blood Pressure (MK-8266-003) (NCT01263314) | Merck Sharp & Dohme LLC | 2010-11-01 |
| Code Status Video in the Intensive Care Unit: Video Assisted Patient Education (NCT01610076) | Mayo Clinic | 2010-11-01 |
| Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye (NCT01319773) | Allergan | 2010-11-01 |
| Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission (NCT01248273) | Memorial Sloan Kettering Cancer Center | 2010-11-01 |
| Effects of Exercise Training in Patients With Permanent Atrial Fibrillation (NCT01721863) | National Taiwan University Hospital | 2010-11-01 |
| Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic Dysfunction (NCT01358565) | Pfizer | 2010-11-01 |
| A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcinoma (ASET) (NCT01265368) | Mologen AG | 2010-11-01 |
| A Study of LY2584702 in Solid Tumors (NCT01241461) | Eli Lilly and Company | 2010-11-01 |
| Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects (NCT01270984) | Chong Kun Dang Pharmaceutical | 2010-11-01 |
| AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer (NCT01182246) | Axcentua Pharmaceuticals AB | 2010-11-01 |
| Pentriox - Induction of Oxidative Stress (NCT02188472) | Henrik Enghusen Poulsen | 2010-11-01 |
| Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML (NCT01161550) | Washington University School of Medicine | 2010-11-01 |
| Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza (NCT01227798) | University Health Network, Toronto | 2010-11-01 |
| Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations (NCT00943943) | M.D. Anderson Cancer Center | 2010-10-29 |
| Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy Volunteers (NCT01235338) | Shire | 2010-10-28 |
| A Study to Learn How BAY94-8862 Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body in Adult Participants With Reduced Kidney Function and in Healthy Participants With Similar Age, Weight and Gender Distribution (NCT04908436) | Bayer | 2010-10-27 |
| Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer (NCT01138384) | NCIC Clinical Trials Group | 2010-10-27 |
| An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas (NCT01240577) | National Cancer Institute (NCI) | 2010-10-26 |
| Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. (NCT01494610) | GlaxoSmithKline | 2010-10-25 |
| Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B (NCT01228669) | Novo Nordisk A/S | 2010-10-25 |
| Developing Biomarkers of Dietary Intake (NCT01237093) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2010-10-24 |
| Phase I Study of Colistin Methanesulfonate Sodium (NCT01449838) | GlaxoSmithKline | 2010-10-23 |
| A Safety Study of CNTO 2476 in Patients With Age-Related Macular Degeneration (NCT01226628) | Janssen Research & Development, LLC | 2010-10-21 |
| An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor (NCT01231568) | GlaxoSmithKline | 2010-10-21 |
| Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents (NCT01262391) | Astellas Pharma Inc | 2010-10-20 |
| A Study to Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment. (NCT01266941) | GlaxoSmithKline | 2010-10-18 |
| Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer (NCT01303705) | Providence Health & Services | 2010-10-14 |
| A 3-Part Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0980, the Effect of Food, and the Effect of Rabeprazole on the Pharmacokinetics of the Tablet (NCT01287091) | Genentech, Inc. | 2010-10-14 |
| Trial to Evaluate the Pharmacokinetics and Safety Profile of BAY94-9027 Following Single and Multiple Dose Administration (NCT01184820) | Bayer | 2010-10-13 |
| A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer (NCT01220999) | Ludwig Institute for Cancer Research | 2010-10-12 |
| Pilot Study of Repetitive Transcranial Magnetic Stimulation in Cocaine Craving (NCT01222806) | National Institute on Drug Abuse (NIDA) | 2010-10-11 |
| Safety and Immunogenicity Study to Assess TDV, a Live Attenuated Tetravalent Vaccine for Prevention of Dengue Fever (NCT01224639) | Inviragen Inc. | 2010-10-11 |
| MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2) (NCT01152255) | Merck Sharp & Dohme LLC | 2010-10-10 |
| Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers (NCT01431937) | GlaxoSmithKline | 2010-10-10 |
| RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia (NCT01236586) | National Cancer Institute (NCI) | 2010-10-08 |
| Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis (NCT01130844) | Shire | 2010-10-08 |
| A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects (NCT01262885) | GlaxoSmithKline | 2010-10-07 |
| Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (NCT01198067) | M.D. Anderson Cancer Center | 2010-10-06 |
| Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas (NCT01193842) | National Cancer Institute (NCI) | 2010-10-06 |
| Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa (NCT01263379) | Abeona Therapeutics, Inc | 2010-10-05 |
| A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene (NCT01219699) | Novartis Pharmaceuticals | 2010-10-05 |
| An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid Tumours (NCT01206816) | Boehringer Ingelheim | 2010-10-04 |
| Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer (NCT01162200) | University of Texas Southwestern Medical Center | 2010-10-04 |
| Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler (NCT01213849) | GlaxoSmithKline | 2010-10-04 |
| Assessment of Coronary Plaque Composition Using Optical Coherence Tomography (NCT01642173) | Mayo Clinic | 2010-10-01 |
| Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCL (NCT01241734) | Hackensack Meridian Health | 2010-10-01 |
| ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma (NCT01219790) | Institut Cancerologie de l'Ouest | 2010-10-01 |
| Pilot Study of Fenofibrate for PSC (NCT01142323) | University of Miami | 2010-10-01 |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT01233505) | National Cancer Institute (NCI) | 2010-10-01 |
| Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients (NCT01215734) | Vanderbilt-Ingram Cancer Center | 2010-10-01 |
| A Study of Fostamatinib in Subjects With Impaired Hepatic (Liver) Function (NCT01222455) | AstraZeneca | 2010-10-01 |
| Safety, Tolerability and Relative Bioavailability of Pegvisomant in Healthy Subjects (NCT01181973) | Pfizer | 2010-10-01 |
| A Pilot Study to Investigate Plasma Bupivacaine Concentrations in Children Receiving Total Intravenous Anaesthesia and Caudal Analgesia (NCT01216007) | University of British Columbia | 2010-10-01 |
| Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults (NCT01151319) | University of Oxford | 2010-10-01 |
| A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male Subjects (NCT01258777) | Centocor, Inc. | 2010-10-01 |
| Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT01154439) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2010-10-01 |
| Pharmacokinetic Study of Primaquine and Chloroquine in Healthy Subjects (NCT01218932) | University of Oxford | 2010-10-01 |
| Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Anesthetized Children (NCT01219322) | Sheba Medical Center | 2010-10-01 |
| A Study of Olaratumab in Soft Tissue Sarcoma (NCT01185964) | Eli Lilly and Company | 2010-10-01 |
| Medications Development for Drug Abuse Disorders (NCT01188421) | Johns Hopkins University | 2010-10-01 |
| "BP as a New Device for Surgery and Solid Cancer and Hematopoietic System Tumors Treatment. Effects of BP Implantation" (NCT02328352) | University of Roma La Sapienza | 2010-10-01 |
| Effectiveness of Modified Ophthalmic Draping Method in Preventing Carbon Dioxide Accumulation in Patient Undergoing Eye Surgery Under Local Anesthesia (NCT02036034) | University of Malaya | 2010-10-01 |
| Effect of Short-term Chinese Tea-flavor Liquor Consumption (NCT01294995) | Zhejiang University | 2010-10-01 |
| Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia (NCT01189279) | Allergan | 2010-10-01 |
| SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg (NCT01227291) | Sylentis, S.A. | 2010-10-01 |
| Effects of the Consumption of California Walnuts on Cardiovascular Health (NCT01235390) | University of California, Davis | 2010-10-01 |
| A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together. (NCT01243957) | Eli Lilly and Company | 2010-10-01 |
| Exploratory Study of Breast Cancer With ABY025 (NCT01216033) | Biomedical Radiation Sciences | 2010-10-01 |
| Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Different Oral Doses of BIIB 722 CL Tablets in Healthy Volunteers (NCT02268604) | Boehringer Ingelheim | 2010-10-01 |
| TMC435 HPC1004 - Phase I Study Investigating the Pharmacokinetics of TMC435 in Healthy Chinese Volunteers (NCT01224197) | Tibotec Pharmaceuticals, Ireland | 2010-10-01 |
| Safety and Immunogenicity Study of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adults (NCT01215149) | International AIDS Vaccine Initiative | 2010-10-01 |